Vera Therapeutics, Inc.

NASDAQ:VERA

28.18 (USD) • At close March 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -152.148-95.99-89.056-32.609-53.413-11.854
Depreciation & Amortization 0.105-4.086-0.8460.1760.2510.509
Deferred Income Tax 000-1.7991.1850.104
Stock Based Compensation 20.80211.4938.8873.0120.3310.263
Change In Working Capital 2.66-5.8696.7473.5110.1230.516
Accounts Receivables 000000.159
Inventory 00000-0.159
Accounts Payables -3.453-0.87310.6060.4750.567-0.291
Other Working Capital 6.113-4.996-3.8593.036-0.4440.807
Other Non Cash Items -6.0982.2716.6724.00116.7140.173
Operating Cash Flow -134.679-92.181-67.596-23.708-34.809-10.289
Investing Activities:
Investments In Property Plant And Equipment -0.972-0.063-0.0620-0.099-0.125
Acquisitions Net 000.070.7960.0570
Purchases Of Investments -711.987-224.93-148.49000
Sales Maturities Of Investments 278.958185.56278000
Other Investing Activites 8.9720-0.07-500
Investing Cash Flow -425.029-39.431-70.552-4.204-0.042-0.125
Financing Activities:
Debt Repayment 024.74119.8164.9215.472-0.188
Common Stock Issued 632.53711586.13151.17679.8410.051
Common Stock Repurchased -0.01300000
Dividends Paid 000000
Other Financing Activities -25.851-6.2-4.014-2.21579.8180.051
Financing Cash Flow 606.673133.541101.93353.88285.29-0.137
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 46.9651.929-36.21525.9750.439-10.551
Cash At End Of Period 92.64645.68143.75279.96753.9973.558